GlassScriptPhysician profile
Donna M Westermann
NPI 1174663272
$302.43
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.92 · 2022: $145 · 2023: $98.14 · 2024: $47.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $68.35 | 2022-2023 | |
| Gilead Sciences, INC. | $34.23 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $31.89 | 2024 | Lynparza |
| Pharmacyclics LLC, An Abbvie Company | $30.34 | 2023 | Imbruvica, Epkinly |
| Regeneron Healthcare Solutions, INC. | $27.71 | 2022 | |
| Pfizer INC. | $22.01 | 2023 | |
| Amgen INC. | $21.39 | 2023 | Kyprolis |
| Janssen Biotech, INC. | $20.17 | 2022 | |
| Coherus Oncology, INC. | $18.84 | 2022 | |
| Adc Therapeutics America, INC. | $15.33 | 2024 | |
| Lilly USA, LLC | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Westermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.